David Sünderhauf is a PhD student investigating the use of CRISPR-Cas9 biotechnology to remove antibiotic resistance genes from bacterial communities.
This work is exploring how resistance genes can be removed from a range of diverse bacteria, stopping the widespread dispersal of antibiotic resistance within a bacterial community.
David is funded by the Medical Research Council, supervised by Professor Will Gaze, and is based at the Centre’s labs in Penryn.
He completed his undergraduate degree in immunology at the University of Aberdeen before moving to Cornwall to complete an MRes in bacterial evolutionary ecology.
You can also find David on the van Houte lab’s webpages.
This project is investigating the use of CRISPR-Cas9 biotechnology to remove antibiotic resistance genes from bacterial communities.
Research at the Centre is part of an unprecedented cross council collaboration to tackle the rising threat of antibiotic resistance.
Described as “A Silent Tsunami”, anti-microbial resistance is one of the biggest threats to human health in our life time. It’s predicted that currently 700,000 people die due to AMR…